Biophytis SA · LS:A403QV

Biophytis SA financial statements

Biophytis SA's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in EUR

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue0000000000
Cost of revenue298.0K803.0K484.0K311.0K280.0K262.0K227.0K204.0K167.0K65.0K
Gross profit-298.0K-803.0K-484.0K-311.0K-280.0K-262.0K-227.0K-204.0K-167.0K-65.0K
Research and development4.47M10.4M16.0M19.7M9.92M9.09M9.51M7.04M5.12M1.57M
Selling, general and administrative5.12M5.49M7.24M7.15M4.02M6.59M4.35M2.87M2.82M3.07M
Operating income-8.50M-14.3M-23.3M-26.8M-13.9M-15.7M-13.9M-9.91M-7.94M-3.10M
Depreciation and amortization298.0K803.0K484.0K311.0K280.0K262.0K227.0K204.0K167.0K65.0K
EBITDA-8.20M-13.5M-22.8M-26.5M-13.7M-15.4M-13.6M-9.70M-7.78M-3.03M
Interest expense872.0K1.25M1.60M4.43M4.37M2.53M185.0K3.29M35.0K172.5K
Income before tax-10.4M-18.6M-24.2M-31.2M-25.5M-17.8M-14.1M-11.4M-7.95M-3.29M
Income tax-1.15M-1.56M-3.41M2.28M-3.33M-28.0K-72.0K1.50M13.0K65.0K
Net income-10.4M-17.0M-24.2M-33.5M-25.5M-18.9M-14.0M-11.4M-7.95M-5.23M
Earnings per share, basic-2.00-12.54-55.40-113.38-170.19-448.88-418.32-496.65-512.93-430.09

Balance sheet

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash and equivalents78.0K5.57M11.1M23.9M5.85M6.34M14.4M19.9M3.07M9.41M
Short-term investments190.0K368.0K590.0K1.23M12.5M475.0K5.00M10.0M367
Receivables3.47M2.74M5.36M5.12M5.21M7.85M4.69M3.33M2.67M1.19M
Inventory45.0K1.57M-709.0K29.0K46.0K160.0K212.4K
Current assets3.92M8.85M18.6M31.4M24.0M14.7M19.4M23.4M5.89M10.8M
Property, plant and equipment231.0K315.0K584.0K563.0K114.0K185.0K295.0K313.0K276.0K194.0K
Total assets6.90M12.0M22.0M36.3M27.2M17.7M21.9M25.9M8.39M13.5M
Accounts payable4.28M5.39M6.94M7.61M7.99M7.87M4.87M2.40M1.92M701.0K
Current liabilities15.6M12.4M19.3M22.8M22.9M19.7M8.28M3.94M2.91M1.42M
Long-term debt673.0K2.42M4.18M6.07M1.83M5.40M6.38M661.0K820.0K272.0K
Total debt9.84M8.27M14.6M17.6M9.10M15.2M8.20M1.01M1.09M802.8K
Total liabilities16.6M15.8M23.9M30.6M20.4M25.2M14.9M4.76M3.87M1.85M
Shareholders' equity-9.67M-3.86M-1.88M5.83M2.30M-7.54M7.04M21.2M4.55M11.7M
Shares outstanding5.19M1.36M437.1K295.7K149.9K42.2K33.4K23.0K15.5K12.2K

Cash flow

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations-8.64M-12.9M-19.0M-23.8M-9.86M-15.3M-12.1M-8.73M-6.63M-3.21M
Capital spending-9.15M-220.0K-141.0K-344.0K-214.0K-282.0K-113.0K-128.0K-129.0K-6.19K
Free cash flow-8.64M-13.1M-19.1M-24.1M-10.1M-15.6M-12.2M-8.86M-6.76M-3.22M
Cash from investing10.0K370.0K-17.0K12.2M-12.7M-278.0K-104.0K-128.0K-129.0K-6.19K
Cash from financing3.14M7.03M6.13M29.7M22.0M7.50M6.77M25.6M407.0K12.6M
Dividends paid0000000
Share buybacks5.54M16.6M23.5M21.8M-280.0K12.3M
Change in cash-5.49M-5.49M-12.9M18.1M-490.0K-8.07M-5.45M16.8M-6.34M9.42M